Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner’s National Priority Voucher Pilot Program
REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc.…
Advanced Instruments is Now Merged Under the Nova Biomedical Name: One Unified Brand Driving Innovation
WALTHAM, Mass., Oct. 15, 2025 /PRNewswire/ -- We are proud to announce…
Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
October 10, 2025 17:16 ET | Source: Bluejay Diagnostics, Inc. ACTON, Mass.,…
Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 10, 2025 16:41 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 10, 2025 16:05 ET | Source: Vera Therapeutics BRISBANE, Calif., Oct.…
Voho Announces CEO Asfandyar Malik Named to Forbes 30 Under 30 for Innovation in AI and Crypto
October 10, 2025 10:00 ET | Source: Voho London, UK, Oct. 10,…
ZTE hosts Global Summit & User Congress 2025 in Milan under the theme “Expanding Intelligence, Creating Possibilities”
MILAN, Oct. 9, 2025 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ), a…
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
ROCKAWAY, N.J., Oct. 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”),…
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2025 16:01 ET | Source: Intellia Therapeutics, Inc. CAMBRIDGE, Mass.,…
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2025 16:15 ET | Source: Context Therapeutics Inc. PHILADELPHIA, Oct.…
